$Recursion Pharmaceuticals, In

$Recursion Pharmaceuticals, Inc.(RXRX)$ ARPA-H just launched SURPASS, a major program built around AI-driven clinical trial simulation, digital twins and predictive modeling, adaptive trial design, agentic AI for trial operations, and faster drug development.

That is very close to what Recursion is already building through its ClinTech and AI platform.

If Recursion shows up in a SURPASS consortium or award, that could be a serious validation catalyst.

AI drug discovery plus AI clinical trials is exactly where healthcare is heading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":615298557923576,"tweetId":"615298557923576","gmtCreate":1791238665000,"gmtModify":1791252185420,"author":{"id":9000000000000172,"idStr":"9000000000000172","authorId":9000000000000172,"authorIdStr":"9000000000000172","name":"AndrewWalker","avatar":"https://static.tigerbbs.com/60528b508747d2305a5e8066c4645143","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":58,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/7861ae15b9bd45bfbf6e2c3890749f14","width":"640","height":"380"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/7861ae15b9bd45bfbf6e2c3890749f14","width":"640","height":"380"}],"title":"","html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>ARPA-H just launched SURPASS, a major program built around AI-driven clinical trial simulation, digital twins and predictive modeling, adaptive trial design, agentic AI for trial operations, and faster drug development.\nThat is very close to what Recursion is already building through its ClinTech and AI platform.\nIf Recursion shows up in a SURPASS consortium or award, that could be a serious validation catalyst.\nAI drug discovery plus AI clinical trials is exactly where healthcare is heading.\n<img src=\"https://community-static.tradeup.com/news/7861ae15b9bd45bfbf6e2c3890749f14\" tg-width=\"640\" tg-height=\"380\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>ARPA-H just launched SURPASS, a major program built around AI-driven clinical trial simulation, digital twins and predictive modeling, adaptive trial design, agentic AI for trial operations, and faster drug development.\nThat is very close to what Recursion is already building through its ClinTech and AI platform.\nIf Recursion shows up in a SURPASS consortium or award, that could be a serious validation catalyst.\nAI drug discovery plus AI clinical trials is exactly where healthcare is heading.\n<img src=\"https://community-static.tradeup.com/news/7861ae15b9bd45bfbf6e2c3890749f14\" tg-width=\"640\" tg-height=\"380\"></body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ ARPA-H just launched SURPASS, a major program built around AI-driven clinical trial simulation, digital twins and predictive modeling, adaptive trial design, agentic AI for trial operations, and faster drug development. That is very close to what Recursion is already building through its ClinTech and AI platform. If Recursion shows up in a SURPASS consortium or award, that could be a serious validation catalyst. AI drug discovery plus AI clinical trials is exactly where healthcare is heading.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/615298557923576","repostId":0,"isVote":1,"tweetType":1,"viewCount":174,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["SPY","RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":459,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/615298557923576"}